Insider Trading & Ownership of Kevin Tang

Location
4747 Executive Drive, Suite 210, San Diego, CA
Summary
The estimated net worth of Kevin Tang is at least $152M dollars as of August 5, 2025. Kevin Tang is the Director of Aurinia Pharmaceuticals Inc. and owns shares of Aurinia Pharmaceuticals Inc. (AUPH) stock worth about $132M. Kevin Tang is the Chief Executive Officer, Director, 10%+ Owner of Odonate Therapeutics, Inc. and owns shares of Odonate Therapeutics, Inc. stock worth about $20M. Kevin Tang is the Director, 10%+ Owner of Jounce Therapeutics, Inc. and owns shares of Jounce Therapeutics, Inc. stock worth about $18.5K.
Signature
Kevin Tang
All Insider Reports
All Insider Reports

Notify me when Kevin Tang files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Kevin Tang

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
AUPH Aurinia Pharmaceuticals Inc. Director $132M +$26.3M +24.8% Aug 1, 2025
ODT Odonate Therapeutics, Inc. Chief Executive Officer, Director, 10%+ Owner $20M Nov 17, 2021
JNCE Jounce Therapeutics, Inc. Director, 10%+ Owner $18.5K May 3, 2023
RAIN Rain Oncology Inc. 10%+ Owner $0 Jan 26, 2024
OMIC Singular Genomics Systems, Inc. 10%+ Owner $0 Feb 21, 2025
TCRR TCR2 THERAPEUTICS INC. 10%+ Owner $0 Jun 1, 2023
APVO Aptevo Therapeutics Inc. Exit Filing Nov 23, 2021
LJPC LA JOLLA PHARMACEUTICAL CO Director, 10%+ Owner Aug 22, 2022

Insider Transactions Reported by Kevin Tang:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.